Human Cytomegalovirus IE1 Protein Elicits a Type II Interferon-Like
Host Cell Response That Depends on Activated STAT1 but Not
Interferon-γ

1. CannonMJSchmidDSHydeTB

2010

Review of cytomegalovirus seroprevalence and demographic

characteristics associated with infection.

Rev Med Virol

20

202

213

2. MocarskiESShenkTPassRF

2007

Cytomegaloviruses.

KnipeDMHowleyPMGriffinDELambRAMartinMA

Fields virology

Philadelphia

Lippincott Williams and Wilkins

2701

2773

3. RafailidisPIMourtzoukouEGVarbobitisICFalagasME

2008

Severe cytomegalovirus infection in apparently immunocompetent

patients: a systematic review.

Virol J

5

47

4. StreblowDNDumortierJMosesAVOrloffSLNelsonJA

2008

Mechanisms of cytomegalovirus-accelerated vascular disease:

induction of paracrine factors that promote angiogenesis and wound

healing.

Curr Top Microbiol Immunol

325

397

415

5. Soderberg-NauclerC

2008

HCMV microinfections in inflammatory diseases and

cancer.

J Clin Virol

41

218

223

6. MichaelisMDoerrHWCinatlJ

2009

The story of human cytomegalovirus and cancer: increasing

evidence and open questions.

Neoplasia

11

1

9

7. CrumpackerCS

2010

Invited commentary: human cytomegalovirus, inflammation,

cardiovascular disease, and mortality.

Am J Epidemiol

172

372

374

8. BrunnerSHerndler-BrandstetterDWeinbergerBGrubeck-LoebensteinB

2010

Persistent viral infections and immune aging.

Ageing Res Rev

In press

9. BrittW

2008

Manifestations of human cytomegalovirus infection: proposed

mechanisms of acute and chronic disease.

Curr Top Microbiol Immunol

325

417

470

10. CraigenJLYongKLJordanNJMacCormacLPWestwickJ

1997

Human cytomegalovirus infection up-regulates interleukin-8 gene

expression and stimulates neutrophil transendothelial

migration.

Immunology

92

138

145

11. GrundyJEDownesKL

1993

Up-regulation of LFA-3 and ICAM-1 on the surface of fibroblasts

infected with cytomegalovirus.

Immunology

78

405

412

12. ZhuHCongJPMamtoraGGingerasTShenkT

1998

Cellular gene expression altered by human cytomegalovirus: global

monitoring with oligonucleotide arrays.

Proc Natl Acad Sci U S A

95

14470

14475

13. BrowneEPWingBColemanDShenkT

2001

Altered cellular mRNA levels in human cytomegalovirus-infected

fibroblasts: viral block to the accumulation of antiviral

mRNAs.

J Virol

75

12319

12330

14. ChallacombeJFRechtsteinerAGottardoRRochaLMBrowneEP

2004

Evaluation of the host transcriptional response to human

cytomegalovirus infection.

Physiol Genomics

18

51

62

15. BrowneEPShenkT

2003

Human cytomegalovirus UL83-coded pp65 virion protein inhibits

antiviral gene expression in infected cells.

Proc Natl Acad Sci U S A

100

11439

11444

16. SimmenKASinghJLuukkonenBGLopperMBittnerA

2001

Global modulation of cellular transcription by human

cytomegalovirus is initiated by viral glycoprotein B.

Proc Natl Acad Sci U S A

98

7140

7145

17. HertelLMocarskiES

2004

Global analysis of host cell gene expression late during

cytomegalovirus infection reveals extensive dysregulation of cell cycle gene

expression and induction of pseudomitosis independent of US28

function.

J Virol

78

11988

12011

18. ChanGBivins-SmithERSmithMSSmithPMYurochkoAD

2008

Transcriptome analysis reveals human cytomegalovirus reprograms

monocyte differentiation toward an M1 macrophage.

J Immunol

181

698

711

19. Tang-FeldmanYJWojtowiczALochheadGRHaleMALiY

2006

Use of quantitative real-time PCR (qRT-PCR) to measure cytokine

transcription and viral load in murine cytomegalovirus

infection.

J Virol Methods

131

122

129

20. RottDZhuJZhouYFBurnettMSZalles-GanleyA

2003

IL-6 is produced by splenocytes derived from CMV-infected mice in

response to CMV antigens, and induces MCP-1 production by endothelial cells:

a new mechanistic paradigm for infection-induced

atherogenesis.

Atherosclerosis

170

223

228

21. DenglerTJRafteryMJWerleMZimmermannRSchonrichG

2000

Cytomegalovirus infection of vascular cells induces expression of

pro-inflammatory adhesion molecules by paracrine action of secreted

interleukin-1beta.

Transplantation

69

1160

1168

22. ChengJKeQJinZWangHKocherO

2009

Cytomegalovirus infection causes an increase of arterial blood

pressure.

PLoS Pathog

5

e1000427

23. ComptonTKurt-JonesEABoehmeKWBelkoJLatzE

2003

Human cytomegalovirus activates inflammatory cytokine responses

via CD14 and Toll-like receptor 2.

J Virol

77

4588

4596

24. DumortierJStreblowDNMosesAVJacobsJMKreklywichCN

2008

Human cytomegalovirus secretome contains factors that induce

angiogenesis and wound healing.

J Virol

82

6524

6535

25. GrundyJELawsonKMMacCormacLPFletcherJMYongKL

1998

Cytomegalovirus-infected endothelial cells recruit neutrophils by

the secretion of C-X-C chemokines and transmit virus by direct

neutrophil-endothelial cell contact and during neutrophil transendothelial

migration.

J Infect Dis

177

1465

1474

26. DeFilippisVR

2007

Induction and evasion of the type I interferon response by

cytomegaloviruses.

Adv Exp Med Biol

598

309

324

27. MarshallEEGeballeAP

2009

Multifaceted evasion of the interferon response by

cytomegalovirus.

J Interferon Cytokine Res

29

609

619

28. SahaBJyothi PrasannaSChandrasekarBNandiD

2010

Gene modulation and immunoregulatory roles of interferon

gamma.

Cytokine

50

1

14

29. SchindlerCPlumleeC

2008

Inteferons pen the JAK-STAT pathway.

Semin Cell Dev Biol

19

311

318

30. LiWX

2008

Canonical and non-canonical JAK-STAT signaling.

Trends Cell Biol

18

545

551

31. PaulusCKraussSNevelsM

2006

A human cytomegalovirus antagonist of type I IFN-dependent signal

transducer and activator of transcription signaling.

Proc Natl Acad Sci U S A

103

3840

3845

32. HuhYHKimYEKimETParkJJSongMJ

2008

Binding STAT2 by the acidic domain of human cytomegalovirus IE1

promotes viral growth and is negatively regulated by SUMO.

J Virol

82

10444

10454

33. KraussSKapsJCzechNPaulusCNevelsM

2009

Physical requirements and functional consequences of complex

formation between the cytomegalovirus IE1 protein and human

STAT2.

J Virol

83

12854

12870

34. GawnJMGreavesRF

2002

Absence of IE1 p72 protein function during low-multiplicity

infection by human cytomegalovirus results in a broad block to viral

delayed-early gene expression.

J Virol

76

4441

4455

35. GreavesRFMocarskiES

1998

Defective growth correlates with reduced accumulation of a viral

DNA replication protein after low-multiplicity infection by a human

cytomegalovirus IE1 mutant.

J Virol

72

366

379

36. MocarskiESKembleGWLyleJMGreavesRF

1996

A deletion mutant in the human cytomegalovirus gene encoding

IE1(491aa) is replication defective due to a failure in

autoregulation.

Proc Natl Acad Sci U S A

93

11321

11326

37. SandfordGRSchumacherUEttingerJBruneWHaywardGS

2010

Deletion of the rat cytomegalovirus immediate-early 1 gene

results in a virus capable of establishing latency, but with lower levels of

acute virus replication and latency that compromise reactivation

efficiency.

J Gen Virol

91

616

621

38. GhazalPVisserAEGustemsMGarciaRBorstEM

2005

Elimination of IE1 significantly attenuates murine

cytomegalovirus virulence but does not alter replicative capacity in cell

culture.

J Virol

79

7182

7194

39. DimitropoulouPCaswellRMcSharryBPGreavesRFSpandidosDA

2010

Differential relocation and stability of PML-body components

during productive human cytomegalovirus infection: Detailed characterization

by live-cell imaging.

Eur J Cell Biol

89

757

768

40. PaulusCNevelsM

2009

The human cytomegalovirus major immediate-early proteins as

antagonists of intrinsic and innate antiviral host reponses.

Viruses

1

760

779

41. CastilloJPKowalikTF

2002

Human cytomegalovirus immediate early proteins and cell growth

control.

Gene

290

19

34

42. WilkinsonGWKellyCSinclairJHRickardsC

1998

Disruption of PML-associated nuclear bodies mediated by the human

cytomegalovirus major immediate early gene product.

J Gen Virol

79

1233

1245

43. KoriothFMaulGGPlachterBStammingerTFreyJ

1996

The nuclear domain 10 (ND10) is disrupted by the human

cytomegalovirus gene product IE1.

Exp Cell Res

229

155

158

44. AhnJHHaywardGS

1997

The major immediate-early proteins IE1 and IE2 of human

cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at

very early times in infected permissive cells.

J Virol

71

4599

4613

45. TavalaiNStammingerT

2009

Interplay between herpesvirus infection and host defense by PML

nuclear bodies.

Viruses

1

1240

1264

46. MaulGG

2008

Initiation of cytomegalovirus infection at ND10.

Curr Top Microbiol Immunol

325

117

132

47. TavalaiNStammingerT

2008

New insights into the role of the subnuclear structure ND10 for

viral infection.

Biochim Biophys Acta

1783

2207

2221

48. SaffertRKalejtaR

2008

Promyelocytic leukemia-nuclear body proteins: herpesvirus

enemies, accomplices, or both?

Future Virology

3

265

277

49. LafeminaRLPizzornoMCMoscaJDHaywardGS

1989

Expression of the acidic nuclear immediate-early protein (IE1) of

human cytomegalovirus in stable cell lines and its preferential association

with metaphase chromosomes.

Virology

172

584

600

50. HayhurstGPBryantLACaswellRCWalkerSMSinclairJH

1995

CCAAT box-dependent activation of the TATA-less human DNA

polymerase alpha promoter by the human cytomegalovirus 72-kilodalton major

immediate-early protein.

J Virol

69

182

188

51. PomaEEKowalikTFZhuLSinclairJHHuangES

1996

The human cytomegalovirus IE1-72 protein interacts with the

cellular p107 protein and relieves p107-mediated transcriptional repression

of an E2F-responsive promoter.

J Virol

70

7867

7877

52. MargolisMJPajovicSWongELWadeMJuppR

1995

Interaction of the 72-kilodalton human cytomegalovirus IE1 gene

product with E2F1 coincides with E2F-dependent activation of dihydrofolate

reductase transcription.

J Virol

69

7759

7767

53. NevelsMPaulusCShenkT

2004

Human cytomegalovirus immediate-early 1 protein facilitates viral

replication by antagonizing histone deacetylation.

Proc Natl Acad Sci U S A

101

17234

17239

54. AhnJHBrignoleEJ3rdHaywardGS

1998

Disruption of PML subnuclear domains by the acidic IE1 protein of

human cytomegalovirus is mediated through interaction with PML and may

modulate a RING finger-dependent cryptic transactivator function of

PML.

Mol Cell Biol

18

4899

4913

55. YurochkoADMayoMWPomaEEBaldwinASJrHuangES

1997

Induction of the transcription factor Sp1 during human

cytomegalovirus infection mediates upregulation of the p65 and p105/p50

NF-kappaB promoters.

J Virol

71

4638

4648

56. LukacDMHarelNYTaneseNAlwineJC

1997

TAF-like functions of human cytomegalovirus immediate-early

proteins.

J Virol

71

7227

7239

57. HwangESZhangZCaiHHuangDYHuongSM

2009

Human cytomegalovirus IE1-72 protein interacts with p53 and

inhibits p53-dependent transactivation by a mechanism different from that of

IE2-86 protein.

J Virol

83

12388

12398

58. MurayamaTMukaidaNSadanariHYamaguchiNKhabarKS

2000

The immediate early gene 1 product of human cytomegalovirus is

sufficient for up-regulation of interleukin-8 gene

expression.

Biochem Biophys Res Commun

279

298

304

59. StraatKLiuCRahbarAZhuQLiuL

2009

Activation of telomerase by human

cytomegalovirus.

J Natl Cancer Inst

101

488

497

60. IwamotoGKMonickMMClarkBDAuronPEStinskiMF

1990

Modulation of interleukin 1 beta gene expression by the immediate

early genes of human cytomegalovirus.

J Clin Invest

85

1853

1857

61. IwamotoGKKonicekSA

1997

Cytomegalovirus immediate early genes upregulate interleukin-6

gene expression.

J Investig Med

45

175

182

62. LeeKJeonKKimJMKimVNChoiDH

2005

Downregulation of GFAP, TSP-1, and p53 in human glioblastoma cell

line, U373MG, by IE1 protein from human cytomegalovirus.

Glia

51

1

12

63. KohKLeeKAhnJHKimS

2009

Human cytomegalovirus infection downregulates the expression of

glial fibrillary acidic protein in human glioblastoma U373MG cells:

identification of viral genes and protein domains involved.

J Gen Virol

90

954

962

64. KlineJNGeistLJMonickMMStinskiMFHunninghakeGW

1994

Regulation of expression of the IL-1 receptor antagonist (IL-1ra)

gene by products of the human cytomegalovirus immediate early

genes.

J Immunol

152

2351

2357

65. CobbsCSSoroceanuLDenhamSZhangWKrausMH

2008

Modulation of oncogenic phenotype in human glioma cells by

cytomegalovirus IE1-mediated mitogenicity.

Cancer Res

68

724

730

66. CastilloJPFrameFMRogoffHAPickeringMTYurochkoAD

2005

Human cytomegalovirus IE1-72 activates ataxia telangiectasia

mutated kinase and a p53/p21-mediated growth arrest

response.

J Virol

79

11467

11475

67. ShenYZhuHShenkT

1997

Human cytomagalovirus IE1 and IE2 proteins are mutagenic and

mediate “hit-and-run” oncogenic transformation in cooperation

with the adenovirus E1A proteins.

Proc Natl Acad Sci U S A

94

3341

3345

68. SourvinosGEverettRD

2002

Visualization of parental HSV-1 genomes and replication

compartments in association with ND10 in live infected

cells.

EMBO J

21

4989

4997

69. EverettRDParsyMLOrrA

2009

Analysis of the functions of herpes simplex virus type 1

regulatory protein ICP0 that are critical for lytic infection and

derepression of quiescent viral genomes.

J Virol

83

4963

4977

70. EverettRDOrrA

2009

Herpes simplex virus type 1 regulatory protein ICP0 aids

infection in cells with a preinduced interferon response but does not impede

interferon-induced gene induction.

J Virol

83

4978

4983

71. NevelsMBruneWShenkT

2004

SUMOylation of the human cytomegalovirus major immediate-early

protein IE1-72kDa contributes to efficient viral replication by promoting

the accumulation of IE2-86kDa.

J Virol

78

7803

7812

72. EverettRD

1984

Transactivation of transcription by herpes virus products:

requirement for two HSV-1 immediate-early polypeptides for maximum

activity.

EMBO J

3

3135

3141

73. MurphyKTraversPWalportM

2008

Janeway's Immunobiology

New York

Garland Science

887

74. LacotteSBrunSMullerSDumortierH

2009

CXCR3, inflammation, and autoimmune diseases.

Ann N Y Acad Sci

1173

310

317

75. CollinsTLJohnsonMGMedinaJC

2007

Antagonists of CXCR3: a review of current

progress.

NeoteKLettsGLMoserB

Chemokine biology - basic research and clinical applications

Basel

Birkhauser

79

88

76. NocentiniGRiccardiC

2009

GITR: a modulator of immune response and

inflammation.

Adv Exp Med Biol

647

156

173

77. DuttaguptaPABoesteanuACKatsikisPD

2009

Costimulation signals for memory CD8+ T cells during viral

infections.

Crit Rev Immunol

29

469

486

78. CroftM

2010

Control of immunity by the TNFR-related molecule OX40

(CD134).

Annu Rev Immunol

28

57

78

79. IshiiNTakahashiTSorooshPSugamuraK

2010

OX40-OX40 ligand interaction in T-cell-mediated immunity and

immunopathology.

Adv Immunol

105

63

98

80. KrogerAKosterMSchroederKHauserHMuellerPP

2002

Activities of IRF-1.

J Interferon Cytokine Res

22

5

14

81. BattistiniA

2009

Interferon regulatory factors in hematopoietic cell

differentiation and immune regulation.

J Interferon Cytokine Res

29

765

780

82. SavitskyDTamuraTYanaiHTaniguchiT

2010

Regulation of immunity and oncogenesis by the IRF transcription

factor family.

Cancer Immunol Immunother

59

489

510

83. MacKenzieCRHeselerKMullerADaubenerW

2007

Role of indoleamine 2,3-dioxygenase in antimicrobial defence and

immuno-regulation: tryptophan depletion versus production of toxic

kynurenines.

Curr Drug Metab

8

237

244

84. CherayilBJ

2009

Indoleamine 2,3-dioxygenase in intestinal immunity and

inflammation.

Inflamm Bowel Dis

15

1391

1396

85. JiaLTianPDingC

2009

Immunoregulatory effects of indoleamine 2, 3-dioxygenase in

transplantation.

Transpl Immunol

21

18

22

86. ItsuiYSakamotoNKakinumaSNakagawaMSekine-OsajimaY

2009

Antiviral effects of the interferon-induced protein guanylate

binding protein 1 and its interaction with the hepatitis C virus NS5B

protein.

Hepatology

50

1727

1737

87. AndersonSLCartonJMLouJXingLRubinBY

1999

Interferon-induced guanylate binding protein-1 (GBP-1) mediates

an antiviral effect against vesicular stomatitis virus and

encephalomyocarditis virus.

Virology

256

8

14

88. ItsuiYSakamotoNKurosakiMKanazawaNTanabeY

2006

Expressional screening of interferon-stimulated genes for

antiviral activity against hepatitis C virus replication.

J Viral Hepat

13

690

700

89. CarterCCGorbachevaVYVestalDJ

2005

Inhibition of VSV and EMCV replication by the interferon-induced

GTPase, mGBP-2: differential requirement for wild-type GTP binding

domain.

Arch Virol

150

1213

1220

90. SamarajiwaSAForsterSAuchettlKHertzogPJ

2009

INTERFEROME: the database of interferon regulated

genes.

Nucleic Acids Res

37

D852

857

91. ErlandssonLBlumenthalRElorantaMLEngelHAlmG

1998

Interferon-beta is required for interferon-alpha production in

mouse fibroblasts.

Curr Biol

8

223

226

92. TaylorRTBresnahanWA

2005

Human cytomegalovirus immediate-early 2 gene expression blocks

virus-induced beta interferon production.

J Virol

79

3873

3877

93. MatsumotoMTanakaNHaradaHKimuraTYokochiT

1999

Activation of the transcription factor ISGF3 by

interferon-gamma.

Biol Chem

380

699

703

94. ZimmermannATrillingMWagnerMWilbornMBubicI

2005

A cytomegaloviral protein reveals a dual role for STAT2 in

IFN-γ signaling and antiviral responses.

J Exp Med

201

1543

1553

95. WesolyJSzweykowska-KulinskaZBluyssenHA

2007

STAT activation and differential complex formation dictate

selectivity of interferon responses.

Acta Biochim Pol

54

27

38

96. NavarroLMowenKRodemsSWeaverBReichN

1998

Cytomegalovirus activates interferon immediate-early response

gene expression and an interferon regulatory factor 3-containing

interferon-stimulated response element-binding complex.

Mol Cell Biol

18

3796

3802

97. SehgalPB

2008

Paradigm shifts in the cell biology of STAT

signaling.

Semin Cell Dev Biol

19

329

340

98. VarinouLRamsauerKKaraghiosoffMKolbeTPfefferK

2003

Phosphorylation of the Stat1 transactivation domain is required

for full-fledged IFN-gamma-dependent innate immunity.

Immunity

19

793

802

99. YangJStarkGR

2008

Roles of unphosphorylated STATs in signaling.

Cell Res

18

443

451

100. BrownSZeidlerMP

2008

Unphosphorylated STATs go nuclear.

Curr Opin Genet Dev

18

455

460

101. SadzakISchiffMGattermeierIGlinitzerRSauerI

2008

Recruitment of Stat1 to chromatin is required for

interferon-induced serine phosphorylation of Stat1 transactivation

domain.

Proc Natl Acad Sci U S A

105

8944

8949

102. RobertsonGHirstMBainbridgeMBilenkyMZhaoY

2007

Genome-wide profiles of STAT1 DNA association using chromatin

immunoprecipitation and massively parallel sequencing.

Nat Methods

4

651

657

103. MesseguerXEscuderoRFarreDNunezOMartinezJ

2002

PROMO: detection of known transcription regulatory elements using

species-tailored searches.

Bioinformatics

18

333

334

104. FarreDRosetRHuertaMAdsuaraJERoselloL

2003

Identification of patterns in biological sequences at the ALGGEN

server: PROMO and MALGEN.

Nucleic Acids Res

31

3651

3653

105. CherringtonJMMocarskiES

1989

Human cytomegalovirus ie1 transactivates the alpha

promoter-enhancer via an 18-base-pair repeat element.

J Virol

63

1435

1440

106. SambucettiLCCherringtonJMWilkinsonGWMocarskiES

1989

NF-kappa B activation of the cytomegalovirus enhancer is mediated

by a viral transactivator and by T cell stimulation.

EMBO J

8

4251

4258

107. LuuPFloresO

1997

Binding of SP1 to the immediate-early protein-responsive element

of the human cytomegalovirus DNA polymerase promoter.

J Virol

71

6683

6691

108. MaloneCLVesoleDHStinskiMF

1990

Transactivation of a human cytomegalovirus early promoter by gene

products from the immediate-early gene IE2 and augmentation by IE1:

mutational analysis of the viral proteins.

J Virol

64

1498

1506

109. ReevesMWoodhallDComptonTSinclairJ

2010

Human cytomegalovirus IE72 protein interacts with the

transcriptional repressor hDaxx to regulate LUNA gene expression during

lytic infection.

J Virol

84

7185

7194

110. GeistLJDaiLY

1996

Cytomegalovirus modulates interleukin-6 gene

expression.

Transplantation

62

653

658

111. WadeMKowalikTFMudryjMHuangESAzizkhanJC

1992

E2F mediates dihydrofolate reductase promoter activation and

multiprotein complex formation in human cytomegalovirus

infection.

Mol Cell Biol

12

4364

4374

112. YurochkoADKowalikTFHuongSMHuangES

1995

Human cytomegalovirus upregulates NF-kappa B activity by

transactivating the NF-kappa B p105/p50 and p65 promoters.

J Virol

69

5391

5400

113. JiangHYPetrovasCSonensheinGE

2002

RelB-p50 NF-kappa B complexes are selectively induced by

cytomegalovirus immediate-early protein 1: differential regulation of

Bcl-x(L) promoter activity by NF-kappa B family members.

J Virol

76

5737

5747

114. ShirakataMTerauchiMAblikimMImadomeKHiraiK

2002

Novel immediate-early protein IE19 of human cytomegalovirus

activates the origin recognition complex I promoter in a cooperative manner

with IE72.

J Virol

76

3158

3167

115. TevethiaMJSpectorDJLeisureKMStinskiMF

1987

Participation of two human cytomegalovirus immediate early gene

regions in transcriptional activation of adenovirus

promoters.

Virology

161

276

285

116. MonickMMGeistLJStinskiMFHunninghakeGW

1992

The immediate early genes of human cytomegalovirus upregulate

expression of the cellular genes myc and fos.

Am J Respir Cell Mol Biol

7

251

256

117. KimJMHongYKimSChoMHYoshidaM

1999

Sequences downstream of the RNA initiation site of the HTLV type

I long terminal repeat are sufficient for trans-activation by human

cytomegalovirus immediate-early proteins.

AIDS Res Hum Retroviruses

15

545

550

118. JohnsonRAYurochkoADPomaEEZhuLHuangES

1999

Domain mapping of the human cytomegalovirus IE1-72 and cellular

p107 protein-protein interaction and the possible functional

consequences.

J Gen Virol

80

1293

1303

119. KimSYuSSKimVN

1996

Essential role of NF-kappa B in transactivation of the human

immunodeficiency virus long terminal repeat by the human cytomegalovirus 1E1

protein.

J Gen Virol

77

83

91

120. WalkerSHagemeierCSissonsJGSinclairJH

1992

A 10-base-pair element of the human immunodeficiency virus type 1

long terminal repeat (LTR) is an absolute requirement for transactivation by

the human cytomegalovirus 72-kilodalton IE1 protein but can be compensated

for by other LTR regions in transactivation by the 80-kilodalton IE2

protein.

J Virol

66

1543

1550

121. WangXSonensheinGE

2005

Induction of the RelB NF-kappaB subunit by the cytomegalovirus

IE1 protein is mediated via Jun kinase and c-Jun/Fra-2 AP-1

complexes.

J Virol

79

95

105

122. CrumpJWGeistLJAuronPEWebbACStinskiMF

1992

The immediate early genes of human cytomegalovirus require only

proximal promoter elements to upregulate expression of interleukin-1

beta.

Am J Respir Cell Mol Biol

6

674

677

123. LukacDMManuppelloJRAlwineJC

1994

Transcriptional activation by the human cytomegalovirus

immediate-early proteins: requirements for simple promoter structures and

interactions with multiple components of the transcription

complex.

J Virol

68

5184

5193

124. KimJMHongYKimS

2000

Artificial recruitment of Sp1 or TBP can replace the role of IE1

in the synergistic transactivation by IE1 and IE2.

Biochem Biophys Res Commun

269

302

308

125. Dal MontePLandiniMPSinclairJVirelizierJLMichelsonS

1997

TAR and Sp1-independent transactivation of HIV long terminal

repeat by the Tat protein in the presence of human cytomegalovirus

IE1/IE2.

Aids

11

297

303

126. GeistLJHopkinsHADaiLYHeBMonickMM

1997

Cytomegalovirus modulates transcription factors necessary for the

activation of the tumor necrosis factor-alpha promoter.

Am J Respir Cell Mol Biol

16

31

37

127. CinatlJJrNevelsMPaulusCMichaelisM

2009

Activation of telomerase in glioma cells by human

cytomegalovirus: another piece of the puzzle.

J Natl Cancer Inst

101

441

443

128. RamsauerKFarlikMZupkovitzGSeiserCKrogerA

2007

Distinct modes of action applied by transcription factors STAT1

and IRF1 to initiate transcription of the IFN-gamma-inducible gbp2

gene.

Proc Natl Acad Sci U S A

104

2849

2854

129. StrassheimDRiddleSRBurkeDLGeraciMWStenmarkKR

2009

Prostacyclin inhibits IFN-gamma-stimulated cytokine expression by

reduced recruitment of CBP/p300 to STAT1 in a SOCS-1-independent

manner.

J Immunol

183

6981

6988

130. ReichNC

2007

STAT dynamics.

Cytokine Growth Factor Rev

18

511

518

131. MeyerTVinkemeierU

2004

Nucleocytoplasmic shuttling of STAT transcription

factors.

Eur J Biochem

271

4606

4612

132. HaspelRLDarnellJEJr

1999

A nuclear protein tyrosine phosphatase is required for the

inactivation of Stat1.

Proc Natl Acad Sci U S A

96

10188

10193

133. MeyerTMargALemkePWiesnerBVinkemeierU

2003

DNA binding controls inactivation and nuclear accumulation of the

transcription factor Stat1.

Genes Dev

17

1992

2005

134. SubramaniamPSTorresBAJohnsonHM

2001

So many ligands, so few transcription factors: a new paradigm for

signaling through the STAT transcription factors.

Cytokine

15

175

187

135. AndersenPPedersenMWWoetmannAVillingshojMStockhausenMT

2008

EGFR induces expression of IRF-1 via STAT1 and STAT3 activation

leading to growth arrest of human cancer cells.

Int J Cancer

122

342

349

136. GrudinkinPSZeninVVKropotovAVDoroshVNNikolskyNN

2007

EGF-induced apoptosis in A431 cells is dependent on STAT1, but

not on STAT3.

Eur J Cell Biol

86

591

603

137. KennedyAMShogrenKLZhangMTurnerRTSpelsbergTC

2005

17beta-estradiol-dependent activation of signal transducer and

activator of transcription-1 in human fetal osteoblasts is dependent on Src

kinase activity.

Endocrinology

146

201

207

138. SadowskiHBShuaiKDarnellJEJrGilmanMZ

1993

A common nuclear signal transduction pathway activated by growth

factor and cytokine receptors.

Science

261

1739

1744

139. FuXYZhangJJ

1993

Transcription factor p91 interacts with the epidermal growth

factor receptor and mediates activation of the c-fos gene

promoter.

Cell

74

1135

1145

140. GuoDDunbarJDYangCHPfefferLMDonnerDB

1998

Induction of Jak/STAT signaling by activation of the type 1 TNF

receptor.

J Immunol

160

2742

2750

141. SizemoreNAgarwalADasKLernerNSulakM

2004

Inhibitor of kappaB kinase is required to activate a subset of

interferon gamma-stimulated genes.

Proc Natl Acad Sci U S A

101

7994

7998

142. DebAHaqueSJMogensenTSilvermanRHWilliamsBR

2001

RNA-dependent protein kinase PKR is required for activation of

NF-kappa B by IFN-gamma in a STAT1-independent pathway.

J Immunol

166

6170

6180

143. ShultzDBFullerJDYangYSizemoreNRaniMR

2007

Activation of a subset of genes by IFN-gamma requires IKKbeta but

not interferon-dependent activation of NF-kappaB.

J Interferon Cytokine Res

27

875

884

144. ShultzDBRaniMRFullerJDRansohoffRMStarkGR

2009

Roles of IKK-beta, IRF1, and p65 in the activation of chemokine

genes by interferon-gamma.

J Interferon Cytokine Res

29

817

824

145. WeiLFanMXuLHeinrichKBerryMW

2008

Bioinformatic analysis reveals cRel as a regulator of a subset of

interferon-stimulated genes.

J Interferon Cytokine Res

28

541

551

146. DuZWeiLMurtiAPfefferSRFanM

2007

Non-conventional signal transduction by type 1 interferons: the

NF-kappaB pathway.

J Cell Biochem

102

1087

1094

147. GoughDJLevyDEJohnstoneRWClarkeCJ

2008

IFNgamma signaling-does it mean JAK-STAT?

Cytokine Growth Factor Rev

19

383

394

148. Storm van's GravesandeKLayneMDYeQLeLBaronRM

2002

IFN regulatory factor-1 regulates IFN-gamma-dependent cathepsin S

expression.

J Immunol

168

4488

4494

149. WhiteLCWrightKLFelixNJRuffnerHReisLF

1996

Regulation of LMP2 and TAP1 genes by IRF-1 explains the paucity

of CD8+ T cells in IRF-1−/− mice.

Immunity

5

365

376

150. KimuraTKadokawaYHaradaHMatsumotoMSatoM

1996

Essential and non-redundant roles of p48 (ISGF3 gamma) and IRF-1

in both type I and type II interferon responses, as revealed by gene

targeting studies.

Genes Cells

1

115

124

151. TerrisBBaldinVDuboisSDegottCFlejouJF

1995

PML nuclear bodies are general targets for inflammation and cell

proliferation.

Cancer Res

55

1590

1597

152. ChingRWDellaireGEskiwCHBazett-JonesDP

2005

PML bodies: a meeting place for genomic loci?

J Cell Sci

118

847

854

153. ShielsCIslamSAVatchevaRSasieniPSternbergMJ

2001

PML bodies associate specifically with the MHC gene cluster in

interphase nuclei.

J Cell Sci

114

3705

3716

154. VolpiEVChevretEJonesTVatchevaRWilliamsonJ

2000

Large-scale chromatin organization of the major

histocompatibility complex and other regions of human chromosome 6 and its

response to interferon in interphase nuclei.

J Cell Sci

113

1565

1576

155. ChristovaRJonesTWuPJBolzerACosta-PereiraAP

2007

P-STAT1 mediates higher-order chromatin remodelling of the human

MHC in response to IFNgamma.

J Cell Sci

120

3262

3270

156. KumarPPBischofOPurbeyPKNotaniDUrlaubH

2007

Functional interaction between PML and SATB1 regulates

chromatin-loop architecture and transcription of the MHC class I

locus.

Nat Cell Biol

9

45

56

157. MocarskiESJr

2002

Virus self-improvement through inflammation: no pain, no

gain.

Proc Natl Acad Sci U S A

99

3362

3364

158. PowersCDeFilippisVMalouliDFruhK

2008

Cytomegalovirus immune evasion.

Curr Top Microbiol Immunol

325

333

359

159. Miller-KittrellMSparerTE

2009

Feeling manipulated: cytomegalovirus immune

manipulation.

Virol J

6

4

160. CheeranMCHuSShengWSPetersonPKLokensgardJR

2003

CXCL10 production from cytomegalovirus-stimulated microglia is

regulated by both human and viral interleukin-10.

J Virol

77

4502

4515

161. RennesonJDuttaBGorielySDanisBLecomteS

2009

IL-12 and type I IFN response of neonatal myeloid DC to human CMV

infection.

Eur J Immunol

39

2789

2799

162. MezgerMBoninMKesslerTGebhardtFEinseleH

2009

Toll-like receptor 3 has no critical role during early immune

response of human monocyte-derived dendritic cells after infection with the

human cytomegalovirus strain TB40E.

Viral Immunol

22

343

351

163. CaposioPMussoTLuganiniAInoueHGariglioM

2007

Targeting the NF-kappaB pathway through pharmacological

inhibition of IKK2 prevents human cytomegalovirus replication and

virus-induced inflammatory response in infected endothelial

cells.

Antiviral Res

73

175

184

164. GravelSPServantMJ

2005

Roles of an IkappaB kinase-related pathway in human

cytomegalovirus-infected vascular smooth muscle cells: a molecular link in

pathogen-induced proatherosclerotic conditions.

J Biol Chem

280

7477

7486

165. TaylorRTBresnahanWA

2006

Human cytomegalovirus immediate-early 2 protein IE86 blocks

virus-induced chemokine expression.

J Virol

80

920

928

166. JinquanTQuanSJacobiHHJingCMillnerA

2000

CXC chemokine receptor 3 expression on CD34(+) hematopoietic

progenitors from human cord blood induced by granulocyte-macrophage

colony-stimulating factor: chemotaxis and adhesion induced by its ligands,

interferon gamma-inducible protein 10 and monokine induced by interferon

gamma.

Blood

96

1230

1238

167. GoodrumFJordanCTTerhuneSSHighKShenkT

2004

Differential outcomes of human cytomegalovirus infection in

primitive hematopoietic cell subpopulations.

Blood

104

687

695

168. GoodrumFDJordanCTHighKShenkT

2002

Human cytomegalovirus gene expression during infection of primary

hematopoietic progenitor cells: a model for latency.

Proc Natl Acad Sci U S A

99

16255

16260

169. MintonEJTysoeCSinclairJHSissonsJG

1994

Human cytomegalovirus infection of the monocyte/macrophage

lineage in bone marrow.

J Virol

68

4017

4021

170. MaciejewskiJPBrueningEEDonahueREMocarskiESYoungNS

1992

Infection of hematopoietic progenitor cells by human

cytomegalovirus.

Blood

80

170

178

171. MendelsonMMonardSSissonsPSinclairJ

1996

Detection of endogenous human cytomegalovirus in CD34+ bone

marrow progenitors.

J Gen Virol

77

3099

3102

172. von LaerDMeyer-KoenigUSerrAFinkeJKanzL

1995

Detection of cytomegalovirus DNA in CD34+ cells from blood

and bone marrow.

Blood

86

4086

4090

173. AgostiniCCalabreseFReaFFaccoMTosoniA

2001

Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells

infiltrating lung allografts and mediate chemotaxis of T cells at sites of

rejection.

Am J Pathol

158

1703

1711

174. MelterMExeniAReindersMEFangJCMcMahonG

2001

Expression of the chemokine receptor CXCR3 and its ligand IP-10

during human cardiac allograft rejection.

Circulation

104

2558

2564

175. GoddardSWilliamsAMorlandCQinSGladueR

2001

Differential expression of chemokines and chemokine receptors

shapes the inflammatory response in rejecting human liver

transplants.

Transplantation

72

1957

1967

176. ZhaoDXHuYMillerGGLusterADMitchellRN

2002

Differential expression of the IFN-gamma-inducible CXCR3-binding

chemokines, IFN-inducible protein 10, monokine induced by IFN, and

IFN-inducible T cell alpha chemoattractant in human cardiac allografts:

association with cardiac allograft vasculopathy and acute

rejection.

J Immunol

169

1556

1560

177. FahmyNMYamaniMHStarlingRCRatliffNBYoungJB

2003

Chemokine and receptor-gene expression during early and late

acute rejection episodes in human cardiac allografts.

Transplantation

75

2044

2047

178. KaoJKobashigawaJFishbeinMCMacLellanWRBurdickMD

2003

Elevated serum levels of the CXCR3 chemokine ITAC are associated

with the development of transplant coronary artery disease.

Circulation

107

1958

1961

179. FahmyNMYamaniMHStarlingRCRatliffNBYoungJB

2003

Chemokine and chemokine receptor gene expression indicates acute

rejection of human cardiac transplants.

Transplantation

75

72

78

180. HuHAizensteinBDPuchalskiABurmaniaJAHamawyMM

2004

Elevation of CXCR3-binding chemokines in urine indicates acute

renal-allograft dysfunction.

Am J Transplant

4

432

437

181. PanzerUReinkingRRSteinmetzOMZahnerGSudbeckU

2004

CXCR3 and CCR5 positive T-cell recruitment in acute human renal

allograft rejection.

Transplantation

78

1341

1350

182. StreblowDNKreklywichCNAndohTMosesAVDumortierJ

2008

The role of angiogenic and wound repair factors during

CMV-accelerated transplant vascular sclerosis in rat cardiac

transplants.

Am J Transplant

8

277

287

183. StreblowDNKreklywichCYinQDe La MelenaVTCorlessCL

2003

Cytomegalovirus-mediated upregulation of chemokine expression

correlates with the acceleration of chronic rejection in rat heart

transplants.

J Virol

77

2182

2194

184. XanthouGDuchesnesCEWilliamsTJPeaseJE

2003

CCR3 functional responses are regulated by both CXCR3 and its

ligands CXCL9, CXCL10 and CXCL11.

Eur J Immunol

33

2241

2250

185. BuscheAMarquardtABleichAGhazalPAnguloA

2009

The mouse cytomegalovirus immediate-early 1 gene is not required

for establishment of latency or for reactivation in the

lungs.

J Virol

83

4030

4038

186. Soderberg-NauclerCFishKNNelsonJA

1997

Interferon-gamma and tumor necrosis factor-alpha specifically

induce formation of cytomegalovirus-permissive monocyte-derived macrophages

that are refractory to the antiviral activity of these

cytokines.

J Clin Invest

100

3154

3163

187. Soderberg-NauclerCFishKNNelsonJA

1997

Reactivation of latent human cytomegalovirus by allogeneic

stimulation of blood cells from healthy donors.

Cell

91

119

126

188. Soderberg-NauclerCStreblowDNFishKNAllan-YorkeJSmithPP

2001

Reactivation of latent human cytomegalovirus in CD14(+)

monocytes is differentiation dependent.

J Virol

75

7543

7554

189. HahnGJoresRMocarskiES

1998

Cytomegalovirus remains latent in a common precursor of dendritic

and myeloid cells.

Proc Natl Acad Sci U S A

95

3937

3942

190. ReevesMSinclairJ

2008

Aspects of human cytomegalovirus latency and

reactivation.

Curr Top Microbiol Immunol

325

297

313

191. SinclairJ

2008

Human cytomegalovirus: Latency and reactivation in the myeloid

lineage.

J Clin Virol

41

180

185

192. HummelMAbecassisMM

2002

A model for reactivation of CMV from latency.

J Clin Virol

25

Suppl 2

S123

136

193. DelnesteYCharbonnierPHerbaultNMagistrelliGCaronG

2003

Interferon-gamma switches monocyte differentiation from dendritic

cells to macrophages.

Blood

101

143

150

194. NetterwaldJYangSWangWGhannySCodyM

2005

Two gamma interferon-activated site-like elements in the human

cytomegalovirus major immediate-early promoter/enhancer are important for

viral replication.

J Virol

79

5035

5046

195. ReddehaseMJSimonCOSeckertCKLemmermannNGrzimekNK

2008

Murine model of cytomegalovirus latency and

reactivation.

Curr Top Microbiol Immunol

325

315

331

196. ReddehaseMJ

2000

The immunogenicity of human and murine

cytomegaloviruses.

Curr Opin Immunol

12

390

396

197. GrundyJEShanleyJDGriffithsPD

1987

Is cytomegalovirus interstitial pneumonitis in transplant

recipients an immunopathological condition?

Lancet

2